Biotechnology | Disease | FDA | Therapeutics
US FDA approves Vera’s kidney disease drug
On Jul. 7, 2026, the U.S. Food and Drug Administration has approved Vera Therapeutics’ drug to treat patients…
-
-
Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion
On Jul. 7, 2026, Vertex Pharmaceuticals and Crinetics Pharmaceuticals, a global pharmaceutical company focused on the discovery, development…
-
Biotechnology | Disease | Neurology | Oncology | Rare Disease | Stem Cell
New CRISPR Method Makes It Possible to Control Protein Production in Cells
On Jul. 3, 2026, a research team led by Helmholtz Munich and Ludwig Maximilian University has developed TAPIR,…
-
Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery Worth $600 million
On Jul. 1, 2026, Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, announced a strategic…
-
Professor Chih-Ying Su Leaves U.S. to join Shenzhen Medical Academy of Research and Translation
On Jul. 1, 2026, Professor Chih-Ying Su, previously Professor and Vice Chair of the Department of Neurobiology at…
-
Hanyang University Researchers Develop AI-designed Shape-Shifting Microneedles for Diabetic Wound Healing
On Jun. 26, 2026, Chronic diabetic wounds heal slowly and are highly vulnerable to infection. Researchers report developing…
-
Self-propelled actin filaments: Novel structures driving spontaneous cell morphogenesis
On Jun. 25, 2026, researchers from the Nara Institute of Science and Technology report that every time a…
-
Contagious Cancer Likely Crossed an Ocean, Triggering Severe Outbreak in Pacific Northwest Clams
On Jun. 23, 2026 – researchers from the Pacific Northwest Research Institute in Seattle announced they have identified…
-
Manning Family Children’s makes history as Louisiana’s first Sickle Cell Disease gene therapy marking his functional cure
On Jun. 22, 2026, Louisiana’s first Sickle Cell Disease gene therapy patient is now set to pursue his…
-
An experimental molecule “reprograms” the brain’s defenses against Alzheimer’s disease
On Jun. 17, 2026, a team led by researcher José Vicente Sánchez Mut at the Institute for Neurosciences…
-
Biotechnology | Disease | NIH | Therapeutics
University of Oklahoma Receives $11.5 Million NIH Award to Establish Statewide Immunoengineering Research Center
On Jun. 11, 2026, the University of Oklahoma (OU) announced it had received an $11.5 million award from…
-
study finds Indoor air contains greater diversity of airborne fungi than previously thought
On Jun. 5, 2026, researchers from Imperial College London have conducted the UK’s largest-ever longitudinal study of indoor…
-
Lilly gains license for Ascidian’s gene-editing tech to develop kidney disease drugs worth up to $1.9 billion
On Jun. 3, 2026, Ascidian Therapeutics said it has signed a licensing deal for its gene-editing technology with…
-
Scientists Map Proteins From Billion-Year-Old Organism and Discover New Links to Rare Diseases
On May 27, 2026, a University of Texas at Austin-led team has identified genes by comparing groups of…
-
Abbott secures CE Mark for world’s first dual glucose-ketone sensing technology for people with diabetes
On May 27, 2026, Abbott announced it has secured CE Mark for the world’s first dual glucose‑ketone sensing…
-
Central-Eastern Europe’s oldest Neanderthal group identified by DNA taken from teeth
On May 13, 2026, DNA recovered from Neanderthal teeth found in Stajnia Cave in southern Poland shows the…
-
Penny and Phil Knight’s Gift advances research into brain resilience and aging
On May 12, 2026, Stanford University announced a $90 million gift from Penny and Philip H. Knight, MBA…
-
Thousands of previously unknown proteins discovered
On May 6, 2026, a group of international researchers announced they had discovered 1,700 new proteins. The research…
-
UVA Study Reveals How New Weight-Loss Drugs Reshape the Brain
On May 6, 2026, In a study published in Nature, a team led by University of Virginia (UVA)…
-
USC launches transformational AI initiative with $200 million gift
On May 5, 2026, the University of Southern California (USC) announced a transformational initiative that will leverage AI…
-
Canada approves second generic semaglutide, the first G7 country to do so
On May 1, 2026, Health Canada authorized a second generic semaglutide injection. Health Canada is currently reviewing seven other…
-
Researchers create groundbreaking first-draft map of genetic interactions within human cells
On Apr. 30, 2026, researchers at the University of Bonn and University Hospital Bonn have created a groundbreaking…
-
Artificial Intelligence | Biotechnology | Diagnostics | Disease | Genomics | Neurology | Non-Profit Research | Oncology | Therapeutics
Biohub Launches the Virtual Biology Initiative to Galvanize a Global Effort to Create the Open Data Foundation for AI-Accelerated Biolog
On Apr. 29, 2026, Biohub announced the Virtual Biology Initiative, a landmark five-year initiative to galvanize a global…
-
Scientists Create First-Ever ‘Smell Map’
On Apr. 28, 2026, scientists Sandeep (Robert) Datta, professor of neurobiology in the Blavatnik Institute at Harvard Medical…
-
Girl’s sight restored after ‘life-changing’ gene therapy
On Apr. 23, 2026, a research team at the University College London (UCL) and Great Ormond Street Hospital…
-
Biotechnology | Disease | FDA | Therapeutics
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss
On Apr. 23, 2026, the U.S. Food and Drug Administration (FDA) approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual…
-
Kailera nets $625M, biotech’s biggest-ever IPO
On Apr. 17, 2026, Kailera Therapeutics, a high-profile drug startup aiming to compete with Novo Nordisk and Eli…
-
Biotechnology | Diagnostics | Disease | Genomics | Oncology | Therapeutics
Roche Expands Foundation Medicine With Acquisition of SAGA Diagnostics’ Tumor-Informed Molecular Residual Disease Platform for $595 million
On Apr. 15, 2026, Foundation Medicine, an independent affiliate of the Roche group, announced it is set to…
-
Scientists reverse brain aging, with a nasal spray
On Apr. 14, 2026, a landmark study from researchers at the Texas A&M University Naresh K. Vashisht College…
-
Novo Nordisk partners with OpenAI in weight loss drug race
On Apr. 14, 2026, Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI…
